Netherlands· NL-43c5009c1a99

Ofloxacine 400 PCH, filmomhulde tabletten 400 mg

A ofloxacin product containing ofloxacine, registered in Netherlands by Pharmachemie B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC J01MA01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ofloxacineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ofloxacin is registered in 10 of 19 countries.

Countries holding a registration under ATC J01MA01 (ofloxacin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search ofloxacin products by name

Ofloxacin · ATC J01MA01

10 / 19 countries

Belgiumprice
Czechiaprice
Finlandprice
Germany
Japan
Netherlands
Norwayprice
Polandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OFLOXACINE
Manufacturer: Pharmachemie B.V.
Country: Netherlands (NL)
ATC code: J01MA01
ATC class: Ofloxacin
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
27572

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

596 interactions on record for ofloxacin.

Graded by severity as the source publishes them — 86 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ofloxacin against other medicines How interaction checks work

Ofloxacin · interactions on record

596 records

86 severe
216 moderate
51 minor
170 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
PrednisoloneA07EA01severe

73 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ofloxacin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ofloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Floxal, Floxal Edo
Belgium · Trafloxal, Trafloxal Edo
Bulgaria · Медофлоксин, Офлоксацин Дра
Cyprus · Cilox, Medofloxine
Czechia · Floxal, Ofloxacin Unimed Pharma
Germany · Floxal, Floxal Edo
Estonia · Medofloxine, Ofloxin
Spain · Exocin, Oflovir
Finland · Exocin
France · Exocine, Monoflocet
United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
Greece · Exocin, Oxatrex
Croatia · Uniflox
Hungary · Floxal, Grenis-Oflo
Ireland · Exocin
Italy · Dunaflot, Exocin
Lithuania · Ofloxin, Uniflox
Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
Latvia · Ofloxin, Uniflox
Malta · Uniflox Unimed Pharma
Poland · Floxal, Oflodinex
Portugal · Audret, Bioquil
Romania · Floxal, Ofloxacină Laropharm
Sweden · Ofloxacin Mibe
Slovakia · Medofloxine, Ofloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/2bfc6570-85af-4647-b984-0076fa4b8e61
GET /v1/drugs/2bfc6570-85af-4647-b984-0076fa4b8e61?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h27572_smpc.pdf",
  "strength": null,
  "atc_label": "Ofloxacin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg27572",
  "excipients": [
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOL",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "STARCH, PREGELATINISED (NOT FROM WHEAT STARCH)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "OFLOXACINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h27572.pdf",
  "authorised_at": "2002/07/30",
  "procedure_number": "NL/H/4742/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "27572",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about ofloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console